Literature DB >> 12623123

Tumor necrosis factor alpha-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors.

Seong G Kim1, Kelly A Soltysiak, Zhan-Guo Gao, Tong-Shin Chang, Eunju Chung, Kenneth A Jacobson.   

Abstract

The physiological role of the uracil nucleotide-preferring P2Y(6) and P2Y(4) receptors is still unclear, although they are widely distributed in various tissues. In an effort to identify their biological functions, we found that activation by UDP of the rat P2Y(6) receptor expressed in 1321N1 human astrocytes significantly reduced cell death induced by tumor necrosis factor alpha (TNF alpha). This effect of UDP was not observed in non-transfected 1321N1 cells. Activation of the human P2Y(4) receptor expressed in 1321N1 cells by UTP did not elicit this protective effect, although both receptors were coupled to phospholipase C. The activation of P2Y(6) receptors prevented the activation of both caspase-3 and caspase-8 resulting from TNF alpha exposure. Even a brief (10-min) incubation with UDP protected the cells against TNF alpha-induced apoptosis. Interestingly, UDP did not protect the P2Y(6)-1321N1 cells from death induced by other methods, i.e. oxidative stress induced by hydrogen peroxide and chemical ischemia. Therefore, it is suggested that P2Y(6) receptors interact rapidly with the TNF alpha-related intracellular signals to prevent apoptotic cell death. This is the first study to describe the cellular protective role of P2Y(6) nucleotide receptor activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623123      PMCID: PMC3402349          DOI: 10.1016/s0006-2952(02)01614-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  50 in total

1.  Glucose deprivation and chemical hypoxia: neuroprotection by P2 receptor antagonists.

Authors:  F Cavaliere; N D'Ambrosi; M T Ciotti; G Mancino; G Sancesario; G Bernardi; C Volonté
Journal:  Neurochem Int       Date:  2001-03       Impact factor: 3.921

2.  MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors.

Authors:  S E Tran; T H Holmstrom; M Ahonen; V M Kahari; J E Eriksson
Journal:  J Biol Chem       Date:  2001-01-25       Impact factor: 5.157

3.  Site of action of suramin and reactive blue 2 in preventing neuronal death induced by dequalinium.

Authors:  C F Chan; S Y Lin-Shiau
Journal:  J Neurosci Res       Date:  2000-12-01       Impact factor: 4.164

4.  Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers.

Authors:  H Nakayama; Y Yamamoto; M Kume; K Yamagami; H Yamamoto; S Kimoto; Y Ishikawa; N Ozaki; Y Shimahara; Y Yamaoka
Journal:  Surgery       Date:  1999-11       Impact factor: 3.982

5.  Adenosine modulation of D-[3H]aspartate release in cultured retina cells exposed to oxidative stress.

Authors:  P Agostinho; P Caseiro; A C Rego; E P Duarte; R A Cunha; C R Oliveira
Journal:  Neurochem Int       Date:  2000-03       Impact factor: 3.921

6.  Differential regulation of the uridine nucleotide-activated P2Y4 and P2Y6 receptors. SER-333 and SER-334 in the carboxyl terminus are involved in agonist-dependent phosphorylation desensitization and internalization of the P2Y4 receptor.

Authors:  A E Brinson; T K Harden
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

7.  A novel pharmacological approach to treating cardiac ischemia. Binary conjugates of A1 and A3 adenosine receptor agonists.

Authors:  K A Jacobson; R Xie; L Young; L Chang; B T Liang
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

8.  Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.

Authors:  N Harada; K Okajima; K Murakami; S Usune; C Sato; K Ohshima; T Katsuragi
Journal:  J Pharmacol Exp Ther       Date:  2000-09       Impact factor: 4.030

9.  Expression of the P2Y6 purinergic receptor in human T cells infiltrating inflammatory bowel disease.

Authors:  G R Somers; F M Hammet; L Trute; M C Southey; D J Venter
Journal:  Lab Invest       Date:  1998-11       Impact factor: 5.662

10.  Chronic administration of adenosine A3 receptor agonist and cerebral ischemia: neuronal and glial effects.

Authors:  D K Von Lubitz; R C Lin; M Boyd; N Bischofberger; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1999-02-19       Impact factor: 4.432

View more
  23 in total

1.  Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells.

Authors:  Qiang Wei; Stefano Costanzi; Qiu-Zhen Liu; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2011-05-23       Impact factor: 5.858

2.  Structure-activity relationships of uridine 5'-diphosphate analogues at the human P2Y6 receptor.

Authors:  Pedro Besada; Dae Hong Shin; Stefano Costanzi; Hyojin Ko; Christophe Mathé; Julien Gagneron; Gilles Gosselin; Savitri Maddileti; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2006-09-07       Impact factor: 7.446

Review 3.  Molecular determinants of P2Y2 nucleotide receptor function: implications for proliferative and inflammatory pathways in astrocytes.

Authors:  Gary A Weisman; M Wang; Q Kong; N E Chorna; J T Neary; Grace Y Sun; Fernando A González; C I Seye; L Erb
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 4.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 5.  Purinoceptors on neuroglia.

Authors:  Alexei Verkhratsky; Alexei Verkhrasky; Oleg A Krishtal; Geoffrey Burnstock
Journal:  Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.590

6.  Attenuation of apoptosis in vitro and ischemia/reperfusion injury in vivo in mouse skeletal muscle by P2Y6 receptor activation.

Authors:  Liaman K Mamedova; Ruibo Wang; Pedro Besada; Bruce T Liang; Kenneth A Jacobson
Journal:  Pharmacol Res       Date:  2008-08-30       Impact factor: 7.658

7.  Pyrimidine Nucleotides Containing a (S)-Methanocarba Ring as P2Y6 Receptor Agonists.

Authors:  Kiran S Toti; Shanu Jain; Antonella Ciancetta; Ramachandran Balasubramanian; Saibal Chakraborty; Ryan Surujdin; Zhen-Dan Shi; Kenneth A Jacobson
Journal:  Medchemcomm       Date:  2017-09-06       Impact factor: 3.597

8.  Regulation of death and survival in astrocytes by ADP activating P2Y1 and P2Y12 receptors.

Authors:  Liaman K Mamedova; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2006-08-28       Impact factor: 5.858

Review 9.  P2 receptors and neuronal injury.

Authors:  Heike Franke; Ute Krügel; Peter Illes
Journal:  Pflugers Arch       Date:  2006-04-28       Impact factor: 3.657

10.  Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors.

Authors:  Liaman K Mamedova; Bhalchandra V Joshi; Zhan-Guo Gao; Ivar von Kügelgen; Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2004-05-01       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.